Comparison of the effectiveness of gene therapy with transforming growth factor‐β or extracorporal shock wave therapy to reduce ischemic necrosis in an epigastric skin flap model in rats
Authors:
- 1 May 2005
- journal article
- research article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 13 (3) , 262-268
Abstract
The induction of neoangiogenesis by exogenous growth factors in failing skin flaps has recently yielded promising results. Gene transfer with virus vectors has been introduced as a highly capable route of administration for growth factors, such as vascular endothelial growth factor or fibroblast growth factor. Extracorporal shock waves (ESW) deliver energy by means of high amplitudes of sound to the target tissue and have been shown to induce angiogenesis. We compared the effectiveness of gene therapy with adenovirus‐mediated transforming growth factor‐β (TGF‐β) and ESW therapy to treat ischemically challenged epigastric skin flaps in a rat model. Thirty male Sprague‐Dawley rats were divided into three groups of 10 each with an 8 × 8 cm epigastric skin flap. Rats received either subdermal injections of adenovirus (Ad) encoding TGF‐β (108 pfu) or ESW treatment with 750 impulses at 0.15 mJ/mm2. The third group received no treatment and served as a control group. Flap viability was evaluated after 7 days and digital images of the epigastric flaps were taken and areas of necrotic zones relative to total flap surface area calculated. Histologic evaluation and increased angiogenesis were confirmed by CD31 immunohistochemistry. Overall, there was a significant increase in mean percent surviving area in the Ad‐TGF‐β group and the ESW group compared to the control group (ESW group: 97.7 ± 1.8% vs. Ad‐TGF‐β: 90.3 ± 4.0% and control group: 82.6 ± 4.3%; p < 0.05). Furthermore, in the ESW group mean percent surviving areas were significantly larger than in the Ad‐TGF‐β group (ESW group: 97.7 ± 1.8% vs. Ad‐TGF‐β: 90.3 ± 4.0%; p < 0.05). Flap vascularization was increased by Ad‐TGF‐β and ESW with numerous vessels, however, there was no significant difference between the two treatment groups. We conclude that treatment with ESW enhances epigastric skin flap survival significantly more than Ad‐TGF‐β treatment and thus represents a modality that is feasible, cost‐effective, and less invasive compared to gene therapy with growth factors to improve blood supply to ischemic tissue.Keywords
This publication has 30 references indexed in Scilit:
- Ras Induction of Superoxide Activates ERK-dependent Angiogenic Transcription Factor HIF-1α and VEGF-A Expression in Shock Wave-stimulated OsteoblastsJournal of Biological Chemistry, 2004
- Recipient intramuscular administration of naked plasmid TGF-β1 attenuates lung graft reperfusion injuryThe Journal of Heart and Lung Transplantation, 2003
- Activation of Nitric Oxide—Cyclic Guanosine Monophosphate Signaling in Kidney by Extracorporeal Shock Wave TherapyJournal of Urology, 2003
- “PINEAPPLE SLICE DRESSING” FOR CORRECTION OF INVERTED NIPPLESPlastic and Reconstructive Surgery, 2003
- Influence of Inflammatory Cytokines on ArteriogenesisMicrocirculation, 2003
- Adenovirus‐mediated angiopoietin‐1 gene therapy enhances skin flap survivalMicrosurgery, 2003
- Effects of Extracorporeal Shock Wave Lithotripsy on Plasma Levels of Nitric Oxide and Cyclic Nucleotides in Human SubjectsJournal of Urology, 2002
- Twenty Years of Shock Wave Research at the Institute for Surgical ResearchEuropean Surgical Research, 2002
- Perforator-Based Flap in Rats: A New Experimental ModelPlastic and Reconstructive Surgery, 2001
- Modification in Flap Design of the Epigastric Artery Flap in Rats–A New Experimental Flap ModelAnnals of Plastic Surgery, 1997